Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Banning pharmaceutical sponsorship: is ethical apartheid the right road ahead?

Gravatt L.

N Z Med J. 2011 Nov 4;124(1345):96-7. No abstract available.

PMID:
22072176
2.

A policy of no pharmaceutical industry sponsorship: a case for health equity.

Pinhao Chao P.

N Z Med J. 2011 Oct 14;124(1344):115-6. No abstract available.

PMID:
22016176
3.

New Zealand doctors and the pharmaceutical industry--time to cut the cord?

Menkes DB.

N Z Med J. 2011 Aug 26;124(1341):6-8. No abstract available.

PMID:
21959629
4.

The pharmaceutical industry has a contribution to make to evidence-based healthcare.

Sheehy K.

N Z Med J. 2012 Jan 20;125(1348):110-1. No abstract available.

PMID:
22282289
5.

Relationships between medical students and drug companies in New Zealand.

Wyber R, Fancourt N, Stone B.

N Z Med J. 2011 Aug 26;124(1341):58-64.

PMID:
21959637
6.

Conflicts of interest--an ever present challenge.

Kopp I.

Dtsch Arztebl Int. 2013 Sep;110(35-36):573-4. doi: 10.3238/arztebl.2013.0573. No abstract available.

7.

The baby with the bathwater.

Buyske J.

Arch Surg. 2010 Jun;145(6):577. No abstract available.

PMID:
20575190
8.

Medical students protest perks from drug companies.

Opar A.

Nat Med. 2006 Oct;12(10):1104. Epub 2006 Sep 29. No abstract available.

PMID:
17024192
9.

The ethics of pharmaceutical industry relationships with medical students.

Rogers WA, Mansfield PR, Braunack-Mayer AJ, Jureidini JN.

Med J Aust. 2004 Apr 19;180(8):411-4.

PMID:
15089733
10.

Attitudes of medical students towards incentives offered by pharmaceutical companies -- perspective from a developing nation -- a cross-sectional study.

Siddiqui UT, Shakoor A, Kiani S, Ali F, Sharif M, Kumar A, Raza Q, Khan N, Alamzaib SM, Farid-ul-Husnain S.

BMC Med Ethics. 2014 May 5;15:36. doi: 10.1186/1472-6939-15-36.

11.

Medical students' attitudes to and contact with the pharmaceutical industry: a survey at eight German university hospitals.

Lieb K, Koch C.

Dtsch Arztebl Int. 2013 Sep;110(35-36):584-90. doi: 10.3238/arztebl.2013.0584. Epub 2013 Sep 2.

12.

Medicine and the pharmaceutical industry: a call to action.

Stiles MM, Barrett B.

Am Fam Physician. 2007 May 15;75(10):1447, 1451; discussion 1451. No abstract available.

13.

Drug representatives: giving you lunch or stealing your soul?

Higgins SP.

Dermatol Online J. 2007 Oct 13;13(4):5.

14.
16.

Doctors and drug companies.

Blumenthal D.

N Engl J Med. 2004 Oct 28;351(18):1885-90. No abstract available.

PMID:
15509823
17.

Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry.

Gough IR, Dickinson I, Maddern G, Grigg M, Hillis DJ.

Med J Aust. 2010 Mar 1;192(5):293-4. No abstract available.

PMID:
20201768
18.

Banning pens and pads misses the main point.

Terry SF, Burke W.

Am J Bioeth. 2003 Summer;3(3):63-5. No abstract available.

PMID:
14594500
19.

[Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].

Gundermann C, Meier-Hellmann A, Bauer M, Hartmann M.

Dtsch Med Wochenschr. 2010 May;135(3):67-70. doi: 10.1055/s-0029-1244818. Epub 2010 Jan 14. German.

PMID:
20077378
20.

[Physicians and the drug industry. "To be like that, you'd better be married."].

Peiró S.

Rev Calid Asist. 2009 Apr;24(2):47-50. doi: 10.1016/S1134-282X(09)70652-9. Spanish. No abstract available.

PMID:
19426926

Supplemental Content

Support Center